Beijing Science Sun Pharmaceutical Co (SZSE:300485) Interest Expense : ¥-1.7 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Beijing Science Sun Pharmaceutical Co's interest expense for the three months ended in Mar. 2024 was ¥ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Beijing Science Sun Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ¥ 6.5 Mil. Beijing Science Sun Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ¥ 0.0 Mil. Beijing Science Sun Pharmaceutical Co has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Beijing Science Sun Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Beijing Science Sun Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Science Sun Pharmaceutical Co Interest Expense Chart

Beijing Science Sun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.14

-0.18

-0.26

-0.03

-0.06

Beijing Science Sun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-0.21	-	-1.53	-

Beijing Science Sun Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.7 Mil.

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beijing Science Sun Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ¥0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥6.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥0.0 Mil.

Beijing Science Sun Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Beijing Science Sun Pharmaceutical Co had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.ssyy.com.cn

Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.

Executives

Ma Li	Directors, executives
Kong Shuang Quan	Executives
Li Jian Hua	Director
Ma Biao	Directors, executives
Li Zhi Bing	Supervisors
Zhang Fan	Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines